RENVELA

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: 4714e07b258b3427
Drug Approval Canada Name: RENVELA
Product Name: RENVELA
Status: Cancelled Post Market
Status Date: 2025-04-10
Original Market Date: 2019-10-25
Din: 02485567
Drug Class: Human
Dosage Form: Powder For Suspension
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 40:18.19
Atc Original: V03AE02 SEVELAMER
Atc Name: v 03 ae 02
Aig Number: 0152763003
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

SEVELAMER CARBONATE

2.4 G / SACHET

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4714e07b258b3427

Type

Standard